本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Krystal Biotech Inc.

176.53
-0.2200-0.12%
盘后176.530.00000.00%16:00 EDT
成交量:31.55万
成交额:5,540.82万
市值:51.09亿
市盈率:35.99
高:178.20
开:176.81
低:173.01
收:176.75
52周最高:207.84
52周最低:122.80
股本:2,894.30万
流通股本:2,297.99万
量比:1.13
换手率:1.37%
股息:- -
股息率:- -
每股收益(TTM):4.91
每股收益(LYR):3.12
净资产收益率:15.61%
总资产收益率:9.23%
市净率:4.91
市盈率(LYR):56.61

数据加载中...

2024/05/06

重要事件披露

Form 8-K - Current report
2024/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/26

重要事件披露

Form 8-K - Current report
2024/02/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/06

重要事件披露

Form 8-K - Current report
2023/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities